EndPoint Technologies and Techsol Corporation Join Forces to Form SciMax Global, to Offer Scientific Communications

Techsol Corporation and EndPoint Technolgoies are extremely proud and excited to announce that both companies have joined forces to form SciMax Global, a new subsidiary company that focuses on providing next-generation technology platform services and value-driven business consulting services for the digital transformation of Scientific Communications and Medical Affairs in the pharmaceutical industry.

With the formation of SciMax Global, Joe Pierce, Founder and President of EndPoint Technologies and Satya Sagi, Founder and CEO of Techsol Corporation along with key team members from both companies have come together to combine the Medical Affairs technology prowess of Techsol and the consulting expertise of EndPoint.

Recommended AI News: Crocus Technology Introduces Its 2nd Gen XtremeSense TMR 2D Angular Sensor

SciMax Global will focus exclusively on Medical Affairs, a third strategic pillar of the new age Pharmaceutical organization, alongside R&D and Commercial. To address key Medical Affairs business challenges for global pharmaceutical and life sciences companies, the company will offer value-driven solutions through 2 broad service categories:

SciMax Consulting Services

• Subject Matter Expertise to develop and execute Medical Affairs Digital Transformation Strategy utilizing Artificial Intelligence, Analytics, Validation, Compliance, Data Privacy, Strategy and Project Management

SciMax Medical Affairs Platform Services

• Unified Cloud Solution for Pharma to support Medical Affairs Programs such as Medical Information, Grants, Publications, Investigator Initiated Studies (IIS/IIT), Expanded Access etc
• Collaboration and Engagement Portals (Med Info, HCP, Patient etc.), Real World Evidence Data Analytics Outcome Assessments

The core SciMax Medical Affairs Technology Platform shall include Techsol’s MedInquirer (MIQ), a leading cloud-based, Medical Information, and Medical Communication System along with the MIQ Self Service Portal and MIQ Mobile App. For more than 5 years, MedInquirer has been used by Global Biopharma Companies and Contact Centers to efficiently, respond to Medical Information Inquiries and to report and triage Adverse Events and Product Complaints. Techsol Corporation first developed MedInquirer in a strategic partnership with one of the largest, US Contact Centers and a top-ten, international, specialty Pharmaceutical Company. SciMax will continue to develop Artificial Intelligence (AI) based solutions, congress technology and conduct MI-Tech Forum events.

Recommended AI News: Centro Implements Transparency Requirements to Bring Advertisers and Publishers Closer

Joe Pierce, says, “I’ve been in the industry for nearly 25 years and Techsol’s MedInquirer is simply the best MI solution available. As EndPoint has continued to expand our professional services, we wanted to be able to bring forward and support the best MI solution to the marketplace. This can be achieved now as SciMax. We are extremely excited to be partnering with Sagi and the Techsol team to continue to develop, implement, and support this comprehensive solution.”

Satya Sagi, commented, “We are very thrilled to partner with Joe Pierce and his EndPoint team. By forming SciMax Global, I believe we have established a powerful combination of exceptional people, strategy, and solutions from both sides to address key challenges in Medical Affairs. We have positioned the SciMax platform to become a market leader through our deep domain expertise, industry relationships, continuous technology innovation, consulting capability and strong commitment to the Pharmaceutical Industry.”

Joe Pierce shall be the Chief Executive Officer (CEO) of SciMax Global. He will lead the strategy formation and execution for the new company. All the team members of EndPoint have joined the SciMax team in various strategic roles. Saad Rahman, previously the Director of Product Management of MedInquirer, shall now assume the role of Chief Product Officer (CPO) to lead the technology platform strategy, development, and delivery. Other team members of Techsol will be involved in administrative, business, development, quality assurance, service and support roles. Sagi will continue as Founder and CEO of Techsol Corporation. As a founding board member of SciMax, he will continue to support the executive team in shaping the overall platform strategy and process execution.

Recommended AI News: Saggezza Launches Salesforce Practice to Help Clients Maximize CRM Investment ROI